MIT Professor Jim Collins leads groundbreaking research using generative AI to design programmable antibacterials targeting drug-resistant pathogens.

Isomorphic Labs launches IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy in predicting protein-ligand structures and binding affinities.

Researchers at University of Michigan developed Prima, an AI system that interprets brain MRI scans in seconds with 97.5% accuracy, automatically flagging emergencies.

Google DeepMind unveils AlphaGenome, an open-source AI model capable of analyzing DNA sequences up to one million base pairs in length and predicting how genetic variations affect gene regulation. The breakthrough technology can decode 98% of the human genome, including previously mysterious non-coding DNA regions, potentially revolutionizing cancer research, rare disease diagnosis, and personalized medicine by identifying disease-causing genetic mutations with unprecedented accuracy.

ScienceDaily reports researchers used machine learning to analyze cancer data from 185 countries, identifying specific policy changes that could improve survival rates in each nation.

Nvidia and pharmaceutical giant Eli Lilly establish co-innovation lab in San Francisco combining compute resources and scientific expertise to accelerate medicine development.